RNAZ
NASDAQ · Biotechnology
Transcode Therapeutics Inc
$3.28
-0.20 (-5.75%)
Open$3.50
Previous Close$3.48
Day High$3.70
Day Low$3.21
52W High$20.99
52W Low$3.30
Volume—
Avg Volume19.6K
Market Cap3.68M
P/E Ratio—
EPS$-45.07
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+504.3% upside
Current
$3.28
$3.28
Target
$19.82
$19.82
$14.35
$19.82 avg
$27.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.00M | 1.95M | 1.64M |
| Net Income | -582,985 | -504,236 | -420,334 |
| Profit Margin | -29.1% | -25.9% | -25.6% |
| EBITDA | -690,102 | -649,673 | -530,744 |
| Free Cash Flow | -724,048 | -502,155 | -609,665 |
| Rev Growth | -0.1% | -1.2% | +14.7% |
| Debt/Equity | 1.05 | 0.94 | 0.99 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |